Donald E. Ingber is a cell biologist and bioengineer. He is the founding director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, the Judah Folkman Professor of Vascular Biology at Harvard Medical School and Boston Children’s Hospital, and Professor of Bioengineering at the Harvard John A. Paulson School of Engineering and Applied Sciences.
Donald Ingber has made significant contributions to the field of biologically inspired engineering. Ingber’s research focuses on how cell structure and mechanics impact cellular biochemistry and tissue development.
Dr Ingber has made significant contributions to the field of biologically inspired engineering, including the development of microfabrication techniques for creating microscale devices that mimic living tissues. He has received numerous awards for his work, including being named to Esquire’s list of the world’s “Best and Brightest” in 2021.
He has also made pioneering contributions to numerous other disciplines including mechanobiology, cytoskeletal biology, extracellular matrix biology, integrin signaling, tumor angiogenesis, tissue engineering, nanobiotechnology, systems biology, and translational medicine.
Dr Ingber has authored more than 470 publications in scientific journals and books, and is an inventor on more than 190 patents spanning anti-cancer therapeutics, tissue engineering, medical devices, drug delivery systems, biomimetic materials, nanotherapeutics, and bioinformatics software.